Paris - Delayed Quote EUR

Sartorius Stedim Biotech S.A. (DIM.PA)

Compare
188.80 -3.60 (-1.87%)
At close: October 25 at 5:35 PM GMT+2
Currency in EUR All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
2,735,500.00
2,775,500.00
3,492,700.00
2,887,000.00
1,910,081.00
--
Cost of Revenue
1,550,100.00
1,542,000.00
1,675,400.00
1,334,000.00
906,759.00
--
Gross Profit
1,185,400.00
1,233,500.00
1,817,400.00
1,553,000.00
1,003,323.00
--
Operating Expense
784,700.00
763,000.00
762,400.00
670,000.00
499,877.00
--
Operating Income
400,700.00
470,500.00
1,055,000.00
883,000.00
503,446.00
--
Net Non Operating Interest Income Expense
-229,500.00
-122,600.00
-9,700.00
-6,700.00
-12,098.00
--
Pretax Income
224,600.00
401,100.00
1,130,400.00
646,700.00
460,694.00
--
Tax Provision
59,900.00
89,000.00
250,500.00
232,400.00
122,095.00
--
Net Income Common Stockholders
160,600.00
309,700.00
876,100.00
414,400.00
335,932.00
--
Diluted NI Available to Com Stockholders
160,600.00
309,700.00
876,100.00
414,400.00
335,932.00
--
Basic EPS
1.68
3.36
9.51
4.50
3.64
--
Diluted EPS
1.68
3.36
9.51
4.50
3.64
--
Basic Average Shares
95,453.23
92,160.63
92,163.10
92,176.83
92,179.10
--
Diluted Average Shares
95,453.23
92,160.63
92,163.10
92,176.83
92,179.10
--
Total Operating Income as Reported
--
--
995,200.00
865,421.00
471,714.00
331,842.00
Total Expenses
2,334,800.00
2,305,000.00
2,437,800.00
2,004,000.00
1,406,636.00
--
Net Income from Continuing & Discontinued Operation
160,600.00
309,700.00
876,100.00
414,400.00
335,932.00
--
Normalized Income
116,381.79
262,786.60
777,760.80
567,278.50
359,144.77
--
Interest Income
-40,200.00
6,200.00
500.00
300.00
509.00
--
Interest Expense
177,500.00
117,000.00
18,600.00
10,400.00
6,819.00
--
Net Interest Income
-229,500.00
-122,600.00
-9,700.00
-6,700.00
-12,098.00
--
EBIT
402,100.00
518,100.00
1,149,000.00
657,100.00
467,513.00
--
EBITDA
697,400.00
755,700.00
1,330,700.00
798,700.00
569,200.00
--
Reconciled Cost of Revenue
1,550,100.00
1,542,000.00
1,675,400.00
1,334,000.00
906,759.00
--
Reconciled Depreciation
295,300.00
237,600.00
181,700.00
141,600.00
101,687.00
--
Net Income from Continuing Operation Net Minority Interest
160,600.00
309,700.00
876,100.00
414,400.00
335,932.00
--
Total Unusual Items Excluding Goodwill
60,300.00
60,300.00
126,400.00
-238,500.00
-31,582.00
--
Total Unusual Items
60,300.00
60,300.00
126,400.00
-238,500.00
-31,582.00
--
Normalized EBITDA
637,100.00
695,400.00
1,204,300.00
1,037,200.00
600,782.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
16,081.79
13,386.60
28,060.80
-85,621.50
-8,369.23
--
12/31/2019 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers